Search

Your search keyword '"Myocardial Infarction"' showing total 59,032 results

Search Constraints

Start Over You searched for: Descriptor "Myocardial Infarction" Remove constraint Descriptor: "Myocardial Infarction"
59,032 results on '"Myocardial Infarction"'

Search Results

1. More than skin deep.

2. Prediction of cardiac attack using ensemble learning.

3. Bioenergetic Metabolism Modulatory Peptide Hydrogel for Cardiac Protection and Repair After Myocardial Infarction.

4. Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.

5. Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.

6. Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome.

7. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.

8. Calcium signaling from sarcoplasmic reticulum and mitochondria contact sites in acute myocardial infarction.

9. M2 macrophage-derived exosomes promote angiogenesis and improve cardiac function after myocardial infarction.

10. Very early vs delayed invasive strategy in high-risk NSTEMI patients without hemodynamic instability: Insight from the KAMIR-NIH.

11. Antioxidant Nanozyme‐Engineered Mesenchymal Stem Cells for In Vivo MRI Tracking and Synergistic Therapy of Myocardial Infarction.

12. Endothelial progenitor cell-derived extracellular vesicles: the world of potential prospects for the treatment of cardiovascular diseases.

13. Inflammation‐Targeted Nanomedicines Alleviate Oxidative Stress and Reprogram Macrophages Polarization for Myocardial Infarction Treatment.

14. Paintable Decellularized‐ECM Hydrogel for Preventing Cardiac Tissue Damage.

15. Long-term clinical outcomes of image-guided percutaneous coronary intervention in acute myocardial infarction from the Korea Acute Myocardial Infarction Registry.

16. The predictive value of lesion-specific pericoronary fat attenuation index for major adverse cardiovascular events in patients with type 2 diabetes.

17. Methodological identification of anomalies episodes in ECG streams: a systematic mapping study.

18. Oral Abstracts.

19. Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study.

21. Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement.

22. Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction.

23. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.

24. Pharmacological inhibition of RUNX1 reduces infarct size after acute myocardial infarction in rats and underlying mechanism revealed by proteomics implicates repressed cathepsin levels.

25. Is the long-term poor prognosis of acute myocardial infarction in patients with mental illness mediated through their poor adherence with recommended healthcare?

26. Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort study.

27. High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.

28. Kardiale Biomarker vor nicht-kardiochirurgischen Eingriffen.

29. The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models.

30. Prevalence of Metabolic Syndrome among Patients with Acute Myocardial Infarction at Al-Ramadi Teaching Hospital, Ramadi City, Iraq.

31. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.

32. Beyond Traditional Pain Relief: A Review of Alternative Analgesics in Myocardial Infarction Patient Management.

33. Short-term effects of nitrogen dioxide on inpatient acute myocardial infarction in Lanzhou, China.

34. Regulatory T-cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction.

35. Direct Comparison of the European Society of Cardiology 0/1-Hour Vs. 0/2-Hour Algorithms in Patients with Acute Chest Pain.

36. Early Celecoxib use in Patients with Traumatic Brain Injury.

37. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study.

38. Intravascular Imaging-Guided Versus Coronary Angiography-Guided Complex PCI: A Meta-analysis of Randomized Controlled Trials.

39. Emergent Coronary Thrombectomy for Acute Myocardial Infarction Immediately Following Craniotomy with Tumor Resection.

40. Salvianic acid A sodium facilitates cardiac microvascular endothelial cell proliferation by enhancing the hypoxia‐inducible factor‐1 alpha/vascular endothelial growth factor signalling pathway post‐myocardial infarction.

41. Nordic Nutrition Recommendations and risk of myocardial infarction and stroke: a prospective cohort study.

42. Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors — Individual patient data analysis of ANNEXA-4 and TICH-NOAC.

43. Association of preoperative beta-blocker use and cardiac complications after major noncardiac surgery: a prospective cohort study.

44. Pulmonary Embolism and Cardiovascular Care: Revolutionary Advances for the Decade Ahead.

45. Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines.

46. Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.

47. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large‐scale, propensity‐matched global retrospective cohort study.

48. A potent and selective activator of large‐conductance Ca2+‐activated K+ channels induces preservation of mitochondrial function after hypoxia and reoxygenation by handling of calcium and transmembrane potential.

49. Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study.

50. Epicardial SMARCA4 deletion exacerbates cardiac injury in myocardial infarction and is related to the inhibition of epicardial epithelial-mesenchymal transition.

Catalog

Books, media, physical & digital resources